Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $86.30 USD
Change Today -4.09 / -4.52%
Volume 362.3K
As of 10:02 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

varian medical systems inc (VAR) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/23/15 - $96.67
52 Week Low
10/15/14 - $76.73
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

varian medical systems inc (VAR) Related Businessweek News

View More BusinessWeek News

varian medical systems inc (VAR) Details

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions in the United States. The company operates in two segments, Oncology Systems and Imaging Components. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, and image processing software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians’ offices, and cancer care clinics. The Imaging Components segment provides X-ray imaging components to large imaging system original equipment manufacturers (OEMs) for use in radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, and industrial applications; and X-ray tubes and flat panel digital image detectors to small OEMs, independent service companies, and end-users for filmless X-ray imaging. This segment also offers Linatron X-ray accelerators, imaging processing software, and image detection products for security and inspection purposes, such as cargo screening at ports and borders, and nondestructive examination in various applications. Varian Medical Systems, Inc. also provides products and systems for delivering proton therapy; and develops various technologies in the areas of digital X-ray imaging, volumetric and functional imaging, and improved X-ray sources. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.

6,800 Employees
Last Reported Date: 11/25/14
Founded in 1948

varian medical systems inc (VAR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $934.6K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $587.0K
Executive Vice President and President of Onc...
Total Annual Compensation: $567.0K
Senior Vice President and President of Imagin...
Total Annual Compensation: $513.8K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $429.9K
Compensation as of Fiscal Year 2014.

varian medical systems inc (VAR) Key Developments

Varian Medical Systems to Equip New York Proton Consortium with ProBeam System

Varian Medical Systems announced that it has entered into an agreement with New York Proton Management LLC to operate The New York Proton Center, the first proton facility in New York State. Varian will provide the center, which will have four treatment rooms and a research room, with its ProBeam system, as well as 10 years of service for approximately $115 million. The center, which will be located in Manhattan, is expected to open for treatment in the first half of 2018. Varian expects to book the equipment portion of the order in the fourth quarter of this fiscal year with the remainder of the order to be booked in accordance with the company's policies over the term of the agreement. Under an agreement with MM Proton I, LLC, the project developer, Varian's international subsidiary in Switzerland will provide $91.5 million in project financing, including a six-and-half-year $73 million senior first lien loan at 9% interest and a six-and-half-year $18.5 million subordinate loan at up to 13.5% interest. Other lenders for the $242.7 million in total project loans include JPMorgan Chase Bank, N.A. and an affiliate of The Goldman Sachs Group, Inc. The project facility is managed by Murphy & McManus, a Boston-based developer of healthcare and life science facilities and Norton Travis of NLT Advisors served as project coordinator on behalf of the consortium. Varian's ProBeam system with Dynamic Peak Scanning is uniquely capable of high-speed intensity modulated proton therapy (IMPT) which is the most precise form of proton therapy available. The Varian installation will include its ARIA® information management system and Eclipse treatment planning software. Varian's ProBeam technology is being used to treat patients at the Scripps Proton Therapy Center in San Diego, the Rinecker Proton Therapy Center in Munich, and at the Paul Scherrer Institute in Switzerland.

Varian Medical Systems, Inc. Unveils VariSeed™ Brachytherapy Treatment Planning Software

Varian Medical Systems, Inc. has introduced a speedier version Of its VariSeed™ brachytherapy treatment planning software at the annual meeting of the American Association of Physicists in Medicine (AAPM) here this week. The Varian exhibit is also featuring a new SmartConnect™ Plus offering for proactively monitoring and servicing its TrueBeam® and Edge™ cancer treatment systems. VariSeed™ Software: The company's new VariSeed software release provides faster, more flexible brachytherapy planning with improvements in workflow and supports both practitioners new to seed implant techniques and those carrying out complex real-time procedures. VariSeed now also features a new VariPath module that supports the use of data and images from transperineal ultrasound-guided biopsies, allowing the planning, tracking and recording of results, with the additional option of fusing these findings with MRI images. Transperineal biopsies are able to reach more of the prostate than the more common transrectal approach, potentially affording clinicians greater confidence in their diagnoses. SmartConnect Plus Proactive Monitoring Service: The company's SmartConnect Plus offering enables service personnel to proactively diagnose, troubleshoot, and make repairs to these systems in real time so clinics can continue to serve patients with minimal disruption. Using this service, Varian's technical experts remotely see what customers see and deal with problems faster than would be possible if service engineers had to be dispatched to the site.

Varian Medical Systems, Inc., Q3 2015 Earnings Call, Jul 29, 2015

Varian Medical Systems, Inc., Q3 2015 Earnings Call, Jul 29, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VAR:US $86.17 USD -4.22

VAR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DENTSPLY International Inc $55.40 USD +1.66
MEDNAX Inc $80.87 USD -0.38
Mettler-Toledo International Inc $334.21 USD -3.54
ResMed Inc $55.55 USD -0.37
Cooper Cos Inc/The $175.04 USD -1.38
View Industry Companies

Industry Analysis


Industry Average

Valuation VAR Industry Range
Price/Earnings 22.3x
Price/Sales 2.9x
Price/Book 5.3x
Price/Cash Flow 21.6x
TEV/Sales 2.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VARIAN MEDICAL SYSTEMS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at